FBLIM1 and central nervous system cancer: Moreover, the predictive power of FBLIM1 expression was estimated by the ROC analysis, which unveiled that FBLIM1 expression could, respectively, forecast the 1-year (0.772), 3-year (0.788), and 5-year (0.729) survival of glioma patients (Figure 3d) in an effective way.